An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C

CompletedOBSERVATIONAL
Enrollment

4,442

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Peg-IFN Alfa-2a

Peg-IFN Alfa-2a according to standard of care and in line with local labeling.

DRUG

Peg-IFN Alfa-2b

Peg-IFN Alfa-2b according to standard of care and in line with local labeling.

DRUG

Ribavirin

Ribavirin according to standard of care and in line with local labeling.

DRUG

Boceprevir

Boceprevir according to standard of care and in line with local labeling.

DRUG

Telaprevir

Telaprevir according to standard of care and in line with local labeling.

Trial Locations (271)

0

Alexandria

Cairo

4

Dublin

8

Dublin

9

Dublin

50

Baabda

100

Taipei

112

Taipei

333

Taoyuan District

504

Rabat

807

Kaohsiung City

1000

Brussels

Skopje

1020

Brussels

1067

Budapest

1070

Brussels

1083

Budapest

1088

Budapest

1097

Budapest

1126

Budapest

1180

Brussels

1190

Brussels

1200

Brussels

2018

Antwerp

2060

Antwerp

2650

Edegem

2660

Balassagyarmat

2800

Tatabánya

3000

Leuven

3500

Hasselt

4000

Liège

4032

Debrecen

4400

Nyíregyháza

4545

Dubai

4800

Verviers

4802

Heusy

5000

Namur

Szolnok

5004

Bouge

5600

Békéscsaba

5700

Gyula

6000

Gilly (Charleroi)

Kecskemét

6061

Montignies-sur-Sambre

6448

Aleppo

6720

Szeged

6900

Lugano

7000

Mons

7400

Kaposvár

7624

Pécs

8000

Székesfehérvár

8400

Ostend

8500

Kortrijk

8800

Roeselare

8900

Zalaegerszeg

8901

Zalaegerszeg

9000

Ghent

9007

Sankt Gallen

9400

Sopron

9700

Szombathely

10082

Cuorgnè (TO)

10138

Tallinn

10243

Berlin

10617

Tallinn

10777

Berlin

11000

Belgrade

11159

Riyadh

11211

Riyadh

11522

Athens

11527

Athens

13041

Safat

13285

Marseille

13616

Aix-en-Provence

13900

Biella

14033

Caen

14564

Nea Kifissia

16132

Genoa

17100

Savona

18057

Rostock

20000

Casablanca

20021

Lahore

20100

Casablanca

20122

Milan

20123

Milan

20132

Milan

20142

Milan

20157

Milan

20162

Milan

21000

Novi Sad

21052

Busto Arsizio

23562

Lübeck

25000

Besançon

25030

Besançon

28887

Omegna (VB)

29121

Piacenza

30029

Nîmes

31025

Kohtla-Järve

31040

Hatay

31059

Toulouse

33100

Udine

33169

Mersin

33604

Pessac

34070

Montpellier

34117

Kassel

34295

Montpellier

34390

Istanbul

34500

Béziers

34751

Villeneuve Maguelone

35033

Rennes

35100

Izmir

35128

Padua

37171

Chambray-lès-Tours

38039

Kayseri

38300

Bourgoin

38700

La Tronche

39120

Magdeburg

40138

Bologna

40237

Düsseldorf

40447

Taichung

41100

Modena

42277

Saint-Priest-en-Jarez

43126

Parma

44606

Saint-Nazaire

45100

Orléans

45122

Essen

50134

Florence

50937

Cologne

51014

Tartu

51092

Reims

52074

Aachen

52100

Arezzo

54511

Vandœuvre-lès-Nancy

56017

Vannes

57124

Livorno

57804

Freyming-Merlebach

59037

Lille

59208

Tourcoing

59462

Lomme

60020

Torrette Di Ancona

60109

Creil

60250

Tokat Province

61080

Trabzon

62000

Rabat

64046

Pau

65185

Karlstad

66013

Chieti

66046

Perpignan

67091

Strasbourg

68100

Alexandroupoli

68167

Mannheim

69009

Lyon

70013

Castellana Grotte

70052

Bisceglie

70124

Bari

71013

San Giovanni Rotondo

72076

Tübingen

72108

Rottenburg

75185

Uppsala

75571

Paris

75651

Paris

75679

Paris

75908

Paris

75970

Paris

76031

Rouen

77104

Meaux

77405

Lagny-sur-Marne

78200

Mantes-la-Jolie

80010

Pärnu

80035

Nola

80054

Amiens

Gragnano

80131

Napoli

80136

Napoli

80138

Napoli

80187

Gävle

81025

Marcianise

83000

Toulon

83100

Avellino

83407

Hyères

84014

Nocera Inferiore

84100

Orange

84489

Burghausen

84902

Avignon

87042

Limoges

89100

Reggio Calabria

90127

Palermo

91014

Évry

91054

Erlangen

92104

Boulogne-Billancourt

92118

Clichy

92151

Suresnes

93806

Épinay-sur-Seine

94010

Créteil

94195

Villeneuve-Saint-Georges

94804

Villejuif

95100

Catania

95107

Argenteuil

95126

Catania

95503

Gonesse

98124

Messina

99999

Beirut

300167

Timișoara

400162

Cluj-Napoca

700554

Iași

700620

Iași

Unknown

Alexandria

Cairo

Giza

Tanta

Beirut

Nabatieh

Casablanca

Fes

Marrakesh

Faisalabad

Gujranwala

Karachi

Lahore

Rawalpindi

Constanța

Ankara

ISTANBULt

06130

Grasse

06202

Nice

06700

Saint-Laurent-du-Var

115 27

Athens

455 00

Ioannina

41 110

Larissa

265 04

Pátrai

546 42

Thessaloniki

H-8400

Ajka

H-1125

Budapest

H-4031

Debrecen

H-3501

Miskolc

00149

Rome

00152

Rome

00161

Rome

00165

Rome

00189

Rome

09042

Cagliari

09100

Cagliari

07100

Sassari

11-236

Beirut

371 Tripoli

Tripoli

P.O Box 35

Muscat

2805-267

Almada

2700-020

Amadora

3810-096

Aveiro

7801-849

Beja

3041-801

Coimbra

8000-386

Faro

1349-019

Lisbon

1649-035

Lisbon

4099-001

Porto

P.O.Box 3051

Doha

021105

Bucharest

022328

Bucharest

21583-Makkah P.O.Box-53356

Holy Makkah

00833

Kaohsiung City

01100

Adana

06100

Ankara

06290

Ankara

06800

Ankara

P.O.Box 1006

Al Ain City

P.O.Box: 5735 - Sharjah, UAE

Sharjah city

DD1 9SY

Dundee

HU3 2JZ

Hull

E1 1BB

London

W2 1NY

London

M8 5RB

Manchester

NG7 2UH

Nottingham

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01447446 - An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter